Skip to main content
. 2021 Dec 14;28(2):410–422. doi: 10.1038/s41591-021-01630-0

Fig. 1. IRRs with 95% CIs for cardiac adverse events following each exposure.

Fig. 1

IRRs are presented for predefined risk periods (0, 1–7, 8–14, 15–21 and 22–28 days) after first or second dose of ChAdOx1, BNT162b2 and mRNA-1273 vaccines and a SARS-CoV-2 positive test for the prerisk period (28 days before exposure). Horizontal bold line in each panel indicates 1.